• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

How Cognitive Bias Undermines Value Creation in Life Sciences M&A

Share:

August 13, 2018

Life sciences mergers and acquisitions are typically based on perceived future value rather than objective financial parameters, but the cognitive biases inherent in subjective assessments can derail deals. Executives need to take emotion out of the equation and rely on relevant data to craft successful transactions.

Mergers and acquisition transactions play a central role in the life sciences sector and are the catalyst for growth and transformation, driving innovation from the laboratory all the way to the patient. Life sciences companies often fall victim to recurring misconceptions that lead to unnecessary failure.

View Full Article

Date: August 13, 2018

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Outcome Capital

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Hydroxychloroquine Market Size to Hit USD 2,339.1 Million and Grow at 5.5% CAGR by 2027Hydroxychloroquine Market Size to Hit USD 2,339.1 Million and Grow at 5.5% CAGR by 2027
  • Elevate Health Taps Innovaccer to Automate Care Management ProcessesElevate Health Taps Innovaccer to Automate Care Management Processes
  • Q&A: How Predictive Analytics and AI can Help Providers TriageQ&A: How Predictive Analytics and AI can Help Providers Triage
  • Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell RegulatorsVallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
  • Boston Scientific to Buy Residual Shares of MillipedeBoston Scientific to Buy Residual Shares of Millipede
  • Eden Health rakes in $60MEden Health rakes in $60M
  • Adding Multimedia Velan Capital Agrees to Support Merger of Lantheus and ProgenicsAdding Multimedia Velan Capital Agrees to Support Merger of Lantheus and Progenics
  • Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening TestMainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications